ChrystalULouisMD
Pediatric Hematology & Oncology • Houston, TXAssistant Professor, Pediatric Hematology & Oncology, Baylor College of Medicine
Are you Dr. Louis?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 51 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
6701 Fannin St
Houston, TX 77030Phone+1 832-822-4890Fax+1 713-798-1144
Summary
- Dr. Chrystal Louis, MD is a pediatric hematologist/oncologist in Houston, Texas. She is currently licensed to practice medicine in Texas and California. She is affiliated with Texas Children's Hospital and is an Assistant Professor at Baylor College of Medicine.
Education & Training
Baylor College of MedicineFellowship, Pediatric Hematology/Oncology, 2004 - 2007
University of California Davis HealthResidency, Pediatrics, 2001 - 2004
Tulane University School of MedicineClass of 2001
Certifications & Licensure
CA State Medical License 2002 - 2026
TX State Medical License 2007 - 2024- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Blood T-Cells and EBV Specific CTLs Expressing GD-2 Specific Chimeric T Cell Receptors to Neuroblastoma Patients Start of enrollment: 2003 Apr 01
- A Phase I/II Study Of Immunization With Lymphotactin And Interleukin 2 Gene Modified Neuroblastoma Tumor Cells Start of enrollment: 2008 Jun 01
- Carboplatin and Docetaxel Followed by Epstein-Barr Virus Cytotoxic T Lymphocytes Start of enrollment: 2009 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- 75 citationsOpen-label, Phase I Study of Nivolumab Combined with nab-Paclitaxel Plus Gemcitabine in Advanced Pancreatic CancerZev A. Wainberg, Howard S. Hochster, Edward J. Kim, Ben George, Aparna Kaylan
Clinical Cancer Research. 2020-09-15 - 9 citationsNomogram for Estimating Overall Survival in Patients With Metastatic Pancreatic Cancer.David Goldstein, Daniel D. Von Hoff, E. Gabriela Chiorean, Michele Reni, Josep Tabernero
Pancreas. 2020-07-01 - 11 citationsSafety and Efficacy Results of a Phase I, Open-Label Study of Concurrent and Delayed Nivolumab in Combination With nab-Paclitaxel and Carboplatin in Advanced Non-small...Jonathan W. Goldman, David M. Waterhouse, Ben George, Peter J. O'Dwyer, Rafia Bhore
Frontiers in Oncology. 2019-11-26
Professional Memberships
- Member
